Clinical Study
Development of Dengue Infection Severity Score
Table 1
Patient profiles by types of dengue infection: dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS).
| Patient profiles | DF () | DHF () | DSS () | value* | Mean ± SD | Mean ± SD | Mean ± SD |
| Demographic | | | | | Male (, %) | 185 (47.3) | 153 (51.7) | 38 (42.2) | 0.888 | Age (year) | | | | 0.903 | Mode of presentation | | | | | Hepatomegaly (, %) | 8 (2.1) | 26 (8.8) | 55 (61.1) | <0.001 | Headache (, %) | 228 (58.3) | 145 (49.0) | 35 (38.9) | <0.001 | Myalgia (, %) | 84 (21.5) | 30 (10.1) | 12 (13.3) | 0.001 | Vomiting (, %) | 244 (62.4) | 216 (73.0) | 56 (62.2) | 0.187 | Cough (, %) | 120 (30.7) | 94 (31.8) | 32 (35.6) | 0.425 | Abdominal pain (, %) | 160 (40.9) | 181 (61.2) | 60 (66.7) | <0.001 | Rash (, %) | 166 (42.5) | 132 (44.6) | 26 (28.9) | 0.124 | Pleural effusion (, %) | 0 (0) | 20 (6.8) | 34 (37.8) | <0.001 | Petechiae (, %) | 27 (6.9) | 26 (8.8) | 14 (15.6) | 0.016 | Any bleeding episodes (, %) | 73 (18.7) | 80 (27.0) | 51 (56.7) | <0.001 | Hemodynamic | | | | | SBP (mmHg) | | | | <0.001 | DBP (mmHg) | | | | 0.084 | Pulse pressure (mmHg) | | | | <0.001 | Hematological | | | | | Hematocrit (%) | | | | <0.001 | Hemoglobin (g/dL) | | | | <0.001 | White cell count (/µL) | | | | <0.001 | Lymphocytes (%) | | | | <0.001 | Neutrophils (%) | | | | <0.001 | Platelet (/µL) | | | | <0.001 | Biochemical | | | | | AST (U/L) | | | | <0.001 | ALT (U/L) | | | | 0.001 | PT (sec) | | | | 0.012 | PTT (sec) | | | | 0.004 | Case management | | | | | Inbound referral (, %) | 43 (11.0) | 78 (26.4) | 48 (53.3) | <0.001 | Discharged | | | | | Alive (, %) | 391 (100.0) | 296 (100.0) | 88 (97.8) | 1.000 | Outbound referral (, %) | 0 (0) | 0 (0) | 2 (2.2) | | In hospital dead (, %) | 0 (0) | 0 (0) | 0 (0) | |
|
|
value from nonparametric test for trend. SD: standard deviation; SBP: systolic blood pressure; DBP: diastolic blood pressure; AST: aspartate aminotransferase; ALT: alanine aminotransferase; PT: prothrombin time; PTT: partial thromboplastin time.
|